Literature DB >> 30871350

Anthracycline Cardiotoxicity.

Anna Narezkina1, Khoban Nasim1.   

Abstract

Entities:  

Keywords:  Editorials; cardiotoxicity; doxorubicin; mice

Year:  2019        PMID： 30871350     DOI： 10.1161/CIRCHEARTFAILURE.119.005910

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  5 in total

Review 1.  Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity.

Authors:  De-Shu Chen; Jing Yan; Ping-Zhen Yang
Journal:  Front Cardiovasc Med       Date:  2022-02-25

2.  Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis.

Authors:  Mary Obasi; Arielle Abovich; Jacqueline B Vo; Yawen Gao; Stefania I Papatheodorou; Anju Nohria; Aarti Asnani; Ann H Partridge
Journal:  Cancer Causes Control       Date:  2021-08-18       Impact factor: 2.506

Review 3.  Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer.

Authors:  Priyanka Banerjee; Sivareddy Kotla; Loka Reddy Velatooru; Rei J Abe; Elizabeth A Davis; John P Cooke; Keri Schadler; Anita Deswal; Joerg Herrmann; Steven H Lin; Jun-Ichi Abe; Nhat-Tu Le
Journal:  Front Cardiovasc Med       Date:  2021-10-20

4.  Relationship Between Serum Concentration of Adrenomedullin and Myocardial Ischemic T Wave Changes in Patients With Lung Cancer.

Authors:  Chen Wu; Da-Wei Lin; Yi-Wen Jiang; Feng Jiang; Zhao-Xia Wang; Yao-Sheng Wang
Journal:  Front Cardiovasc Med       Date:  2022-03-07

Review 5.  Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).

Authors:  Akshay Narkar; James M Willard; Ksenia Blinova
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.